83 related articles for article (PubMed ID: 3543760)
21. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Montastruc JL; Schmitt L; Bagheri H
Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
[TBL] [Abstract][Full Text] [Related]
22. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
[TBL] [Abstract][Full Text] [Related]
23. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary.
Quinn NP
J Neurol; 2003 Jan; 250(1):97. PubMed ID: 12528000
[No Abstract] [Full Text] [Related]
24. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
25. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
[TBL] [Abstract][Full Text] [Related]
26. Drug management of Parkinson's disease.
Kishore A; Snow BJ
Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
[TBL] [Abstract][Full Text] [Related]
27. Controversies in the treatment of Parkinson's disease.
Hershey LA
Ration Drug Ther; 1985 Feb; 19(2):1-4. PubMed ID: 4048474
[No Abstract] [Full Text] [Related]
28. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
29. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
[TBL] [Abstract][Full Text] [Related]
30. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
[TBL] [Abstract][Full Text] [Related]
31. [Bromocriptine in the treatment of Parkinson's disease].
Sepcić J; Ledić P
Neurologija; 1982; 30(1-4):75-81. PubMed ID: 6765062
[No Abstract] [Full Text] [Related]
32. Treatment of Parkinson's disease.
Eadie MJ
Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
[TBL] [Abstract][Full Text] [Related]
33. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
Stern GM; Lees AJ
Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
[TBL] [Abstract][Full Text] [Related]
34. Dopamine agonists in the treatment of Parkinson's disease.
Rinne UK
Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175
[TBL] [Abstract][Full Text] [Related]
35. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
36. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
37. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
[TBL] [Abstract][Full Text] [Related]
38. Update on the treatment of Parkinson's disease.
Wirz D
Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903
[No Abstract] [Full Text] [Related]
39. Treatment of Parkinson's disease. From theory to practice.
Ahlskog JE
Postgrad Med; 1994 Apr; 95(5):52-4, 57-8, 61-4 passim. PubMed ID: 8153048
[TBL] [Abstract][Full Text] [Related]
40. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Kondo T
J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]